ESSA Pharma Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Cash & Equivalents	85.95	103.71	33.7	57.08	137.83	56.32
Short-Term Investments	23.67	23.05	114.37	110.16	57.1	22.01
Cash & Short-Term Investments	109.62	126.76	148.08	167.24	194.93	78.33
Cash Growth	-16.13%	-14.39%	-11.46%	-14.21%	148.85%	46.90%
Other Receivables	0.53	0.16	0.14	0.01	0.49	0.31
Receivables	0.53	0.16	0.14	0.01	0.49	0.31
Prepaid Expenses	0.34	0.3	0.21	1.79	1.99	1.48
Other Current Assets	0.02	0.33	0.38	0.02	0.19	0.18
Total Current Assets	110.5	127.56	148.8	169.06	197.6	80.3
Property, Plant & Equipment	-	0.3	0.07	0.19	0.31	-
Other Long-Term Assets	-	0.26	0.26	0.26	0.26	0.28
Total Assets	110.5	128.11	149.12	169.51	198.17	80.57
Accounts Payable	0.97	2.4	2.03	0.95	1.43	0.68
Accrued Expenses	0.63	0.77	1.39	1.22	2.38	0.47
Current Portion of Leases	-	0.12	0.08	0.13	0.12	0.06
Total Current Liabilities	1.6	3.3	3.5	2.31	3.93	1.2
Long-Term Leases	-	0.21	-	0.08	0.21	-
Other Long-Term Liabilities	-	-	-	-	0.02	0.13
Total Liabilities	1.6	3.51	3.5	2.39	4.16	1.33
Common Stock	279.86	279.86	278.16	278.09	277.42	131.09
Additional Paid-In Capital	58.05	54.81	49.05	44.04	36.44	31.2
Retained Earnings	-226.91	-208	-179.46	-152.88	-117.78	-80.97
Comprehensive Income & Other	-2.1	-2.06	-2.12	-2.14	-2.08	-2.08
Total Common Equity	108.9	124.61	145.63	167.12	194.01	79.24
Shareholders' Equity	108.9	124.61	145.63	167.12	194.01	79.24
Total Liabilities & Equity	110.5	128.11	149.12	169.51	198.17	80.57
Total Debt	-	0.33	0.08	0.21	0.33	0.06
Net Cash (Debt)	109.62	126.43	148	167.03	194.6	78.27
Net Cash Growth	-15.90%	-14.57%	-11.39%	-14.17%	148.61%	57.77%
Net Cash Per Share	2.47	2.86	3.36	3.79	5.06	3.49
Filing Date Shares Outstanding	47.31	44.39	44.14	44.07	43.98	33.6
Total Common Shares Outstanding	44.39	44.39	44.1	44.07	43.98	32.06
Working Capital	108.9	124.26	145.3	166.75	193.67	79.09
Book Value Per Share	2.45	2.81	3.30	3.79	4.41	2.47
Tangible Book Value	108.9	124.61	145.63	167.12	194.01	79.24
Tangible Book Value Per Share	2.45	2.81	3.30	3.79	4.41	2.47

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q